Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-10

FDA Approved: ENDOMETRIN — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ENDOMETRIN (progesterone) from Ferring Pharmaceuticals, updating the product's marketing authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENDOMETRIN (PROGESTERONE)

Snippet

SUPPL AP for ENDOMETRIN (PROGESTERONE)